Fed. Circ. Urged To Upend Actavis' $12M Legal Fee Deduction

By Anna Scott Farrell · March 21, 2023, 1:56 PM EDT

The Federal Circuit should reverse a decision allowing drugmaker Actavis to deduct as regular business expenses $12 million it spent fighting lawsuits as it tried to secure approval to sell generic...

To view the full article, register now.